Director
DIN: 07471437
Anubhav Mehndiratta is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at DR. MUKULRANI HOSPITALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07471437.Anubhav Mehndiratta is currently involved in 3 different roles. Their most recent position is with CHEMTRUST HEALTHCARE LLP as a Designated Partner. The first company Anubhav Mehndiratta was appointed to as a director was DR. MUKULRANI HOSPITALS PRIVATE LIMITED. Anubhav Mehndiratta is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Anubhav Mehndiratta is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at DR. MUKULRANI HOSPITALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07471437.Anubhav Mehndiratta is currently involved in 3 different roles. Their most recent position is with CHEMTRUST HEALTHCARE LLP as a Designated Partner. The first company Anubhav Mehndiratta was appointed to as a director was DR. MUKULRANI HOSPITALS PRIVATE LIMITED. Anubhav Mehndiratta is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
2y 1m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| DR. MUKULRANI HOSPITALS PRIVATE LIMITED | Director | 10-Mar-2016 |
| UNIKA PHARMACEUTICALS PRIVATE LIMITED | Director | 09-Feb-2021 |
| UNIKA PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 09-Feb-2021 |